A phase II study of epidoxorubicin in colorectal cancer and the use of cyclosporin-A in an attempt to reverse multidrug resistance

British Journal of Cancer

Volumn 64, Issue 2, 1991, Pages 361-364

  Verweij, J ^a   Herweijer, H ^a   Oosterom, R ^a   van der Burg, M E L ^a   Planting, A S Th ^a   Seynaeve, C ^a   Stoter, G ^a   Nooter, K ^a,b  

^a ERASMUS MC CANCER INSTITUTE   (Netherlands)

^b Institute of Applied Radiobiology and Immunology ^*  (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIEMETIC AGENT; CYCLOSPORIN; EPIRUBICIN;

ADULT; AGED; ARTICLE; BLOOD LEVEL; CLINICAL ARTICLE; COLORECTAL CANCER; FEMALE; HOT FLUSH; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; LEUKOPENIA; MALE; MULTIDRUG RESISTANCE; PHASE 2 CLINICAL TRIAL; PRIORITY JOURNAL;

ADULT; AGED; COLORECTAL NEOPLASMS; CYCLOSPORINS; DRUG RESISTANCE; EPIRUBICIN; FEMALE; FLOW CYTOMETRY; HUMAN; IN VITRO; LEUKOPENIA; MALE; MIDDLE AGE; SUPPORT, NON-U.S. GOV'T;

EID: 0025739134     PISSN: 00070920     EISSN: 15321827     Source Type: Journal    
DOI: 10.1038/bjc.1991.307     Document Type: Article

References (26)

1. CAIRO, M.S., SIEGEL, S., ANAS, N. & SENDER, L. (1989). Clinical trial of continuous infusion verapamil, bolus vinblastine and continuous infusion VP-16 in drug resistant pediatric tumors. Cancer Res., 49, 1063
2. CHLEBOWSKI, R.T., SILVERBERG, I., PAHAK, T., WEINER, J., KARDINAL, C. & BATEMAN, J.R. (1980). Treatment of advanced colon cancer with 5-fluorouracil versus cyclophosphamide plus 5-fluorouracil. Cancer, 45, 2240
3. DOROSHOW, J.H., MULTHAUF, P., LEONG, L. & 11 others (1990). Prospective randomized comparison of fluorouracil versus flourouracil and high-dose continuous infusion leucovorin calcium for the treatment of advanced measurable colorectal cancer in patients previously unexposed to chemotherapy. J. Clin. Oncol., 8, 491
4. EHRLICHMAN, C.H., FINE, S., WONG, A. & ELKAHIM, T. (1988). A randomized trial of fluorouracil and folinic acid in patients with metastatic colorectal carcinoma. J. Clin. Oncol., 6, 469
5. FALKSON, G. & VOROBIOF, D.A. (1984). Epirubicin in colorectal cancer. In Advances in Anthracycline Chemotherapy: Epirubicin. Bonadonna, G. (ed.), pp. 105-109, Masson Italia Editori
6. FIGUEREDO, A., ARNOLD, A., GOODYEAR, M. & 4 others (1990). Addition of verapamil and tamoxifen to the initial chemotherapy of small cell lung cancer. A phase I/II study. Cancer, 65, 1895
7. FISHMAN, W., KINSTEM, E., KLEIN, M. & 4 others (1982). Clinical relevance of verapamil plasma levels in stable angina pectoris. J. Cardiol., 50, 1180
8. FOJO, A.T. (1989). Multidrug resistance to chemotherapy. Cancer Bull, 41, 26
9. FORD, J.M. & HAIT, W.H. (1990). Pharmacology of drugs that alter multidrug resistance in cancer. Pharmacol. Rev., 42, 155
10. GOLDSTEIN, L.J., GALSKI, H., FOJO, A.T. & 11 others (1989). Expression of a multidrug resistance gene in human cancers. J. Natl Cancer Inst., 81, 116
11. HERWEIJER, H., VAN DEN ENGH, G.J. & NOOTER, K. (1989). A rapid and sensitive flow cytometric method for the detection of multidrug-resistant cells. Cytometry, 10: 463
12. HOLT, D.W., JOHNSTON, A., MARSDE, J.E. & 5 others (1988). Monoclonal antibodies for radioimmunoassay of cyclosporine: a multicenter comparison of their performance with the Sandoz Polyclonal Radioimmunoassay Kit. Clin. Chem., 34, 1091
13. KLOHS, W.D. & STEINKAMPF, R.W. (1988). Possible link between the intrinsic drug resistance of colon tumors and a detoxification mechanism of intestinal cells. Cancer Res., 48, 3025
14. MOERTEL, C.G. (1978). Chemotherapy of gastrointestinal cancer. New Eng. J. Med., 279, 1049
15. NOOTER, K., VAN DEN ENGH, G.J. & SONNEVELD, P. (1983). Quantitative flow cytometric determination of anthracycline content of rat bone marrow cells. Cancer Res., 43, 5126
16. NOOTER, K., OOSTRUM, R., JONKER, R.R., VAN DEKKEN, H., STOKDŸK, W. & VAN DEN ENGH, G. (1989). Effect of Cyclosporin A on daunorubicin accumulation in multidrug resistant P388 leukemia cells measured by real-time flow cytometry. Cancer Chemother. Pharmacol., 23, 296
17. VAN OOSTEROM, A.T., MOURIDSEN, H.T., WILDIERS, J. & 5 others (1984). Doxorubicin versus epirubicin: a preliminary report on an ongoing randomized phase II-III study in pretreated breast cancer patients. In: Advances in Anthracycline Chemotherapy: Epirubicin. Bonnadonna, G. (ed.), pp. 83-91, Masson Italia Editori, Milano
18. OZOLS, R.F. & COWAN, K.M. (1986). New aspects of clinical drug resistance, the role of gene amplification and the reversal of resistance in drug refractory cancer. In Important Advances in Oncology. DeVita, V.T., Heilman, S. & Rosenberg, S.A. (ed.), pp. 129-157, J.B. Lippincott: Philadelphia
19. OZOLS, R.F., CUNNION, R.E., KLECKER, R.W. & 4 others (1987). Verapamil and Adriamycin in the treatment of drug-resistant ovarian cancer patients. J. Clin. Oncol., 5, 641
20. PASTAN, I. & GOTTESMAN, M.M. (1987). Multiple drug resistance in human cancer. N. Engl. J. Med., 316, 1388
21. SHEN, D.W., FOJO, A., CHIN, J.E. & 4 others (1986). Human multidrug resistant cell lines: increased MDR expression can precede gene amplification. Science, 232, 643
22. SILBERMANN, M.H., BOERSMA, A.W.M., JANSSEN, A.L.W., SCHEPER, R.J., HERWEIJER, H. & NOOTER, K. (1989). Effects of Cyclosporin A and verapamil on the intracellular daunorubicin accumulation of Chinese hamster ovary cells with increasing levels of drug-resistance. Int. J. Cancer, 44, 722
23. SLATER, L.M., SWEET, P., STUPECKY, M., WETZEL, M.W. & GUPTA, S. (1986). Cyclosporin A corrects daunorubicin resistance in Ehrlich ascites carcinoma. Br. J. Cancer, 54, 235
24. SONNEVELD, P. & NOOTER, K. (1990). Reversal of drug-resistance by cyclosporin-A in a patient with acute myeloblastic leukemia. Br. J. Haematol., 75, 208
25. TWENTYMAN, P.R., FOX, N.E. & WHITE, D.J.G. (1987). Cyclosporin A and its analogues as modifiers of adriamycin and vincristine resistance in a multidrug resistant human lung cancer cell line. Br. J. Cancer, 56, 55
26. WADLER, S., SCHWARTZ, L., GOLDMAN, M. & 6 others (1989). Fluorouracil and recombinant Alpha-2a-Interferon: an active regimen against advanced colorectal carcinoma. J. Clin. Oncol., 7, 1769